Mucormycosis in COVID-19 Patients: A Case-Control Study

(1) Background: During the second wave of COVID-19, India faced a rapid and sudden surge of not only COVID19-delta variant cases but also mucormycosis, making the infection even more fatal. We conducted a study to determine factors associated with the occurrence of mucormycosis in patients with COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandit, Awadh Kishor, Tangri, Poorvi, Misra, Shubham, Srivastava, Madakasira Vasantha Padma, Bhatnagar, Sushma, Thakar, Alok, Sikka, Kapil, Panda, Smriti, Vishnu, Venugopalan Y., Singh, Rajesh Kumar, Das, Animesh, Radhakrishnan, Divya M., Srivastava, Achal Kumar, Subramaniam, Rajeshwari, Trikha, Anjan, Agarwal, Ayush, Rajan, Roopa, Upadhyay, Vibhor, Parikipandla, Sathish, Singh, Anup, Kairo, Arvind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229175/
https://www.ncbi.nlm.nih.gov/pubmed/35744726
http://dx.doi.org/10.3390/microorganisms10061209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229175/
https://www.ncbi.nlm.nih.gov/pubmed/35744726
http://dx.doi.org/10.3390/microorganisms10061209

Ejemplares similares